Correction: Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism (Annals of the Rheumatic Diseases (2016) 75 (730) DOI: 10.1136/annrheumdis-2015-208094);Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism

Annals of the Rheumatic Diseases

Volumn 75, Issue 4, 2016, Pages 730-7398

  Wigerblad, Gustaf ^a   Bas, Duygu B ^a   Fernades Cerqueira, Cátia ^a   Krishnamurthy, Akilan ^a   Nandakumar, Kutty Selva ^a   Rogoz, Katarzyna ^a   Kato, Jungo ^a   Sandor, Katalin ^a   Su, Jie ^a   Jimenez Andrade, Juan Miguel ^b   Finn, Anja ^a   Farinotti, Alex Bersellini ^a   Amara, Khaled ^a   Lundberg, Karin ^a   Holmdahl, Rikard ^a   Jakobsson, Per Johan ^a   Malmström, Vivianne ^a   Catrina, Anca I ^a   Klareskog, Lars ^a   Svensson, Camilla I ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSIDAD AUTÓNOMA DE TAMAULIPAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CITRULLINATED PROTEIN AUTOANTIBODY; CXCL1 CHEMOKINE; IMMUNOGLOBULIN G; INTERLEUKIN 8; METALLOPROTEINASE; REPARIXIN; UNCLASSIFIED DRUG; 2-(4-ISOBUTYLPHENYL)PROPIONYLMETHANESULFONAMIDE; CHEMOKINE; CITRULLINE; CXCL1 PROTEIN, MOUSE; INTERLEUKIN 8 RECEPTOR; SULFONAMIDE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTHRALGIA; ARTICLE; CELL ACTIVATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MONITORING; MOUSE; NONHUMAN; OSTEOCLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PURIFICATION; RHEUMATOID ARTHRITIS; SPINAL GANGLION; SUPERNATANT; WESTERN BLOTTING; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CASE CONTROL STUDY; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; NOCICEPTION; PHYSIOLOGY;

ANIMALS; ARTHRALGIA; AUTOANTIBODIES; BEHAVIOR, ANIMAL; CASE-CONTROL STUDIES; CHEMOKINE CXCL1; CHEMOKINES; CITRULLINE; INFLAMMATION; INTERLEUKIN-8; MALE; MICE; MICE, INBRED BALB C; NOCICEPTION; OSTEOCLASTS; RECEPTORS, INTERLEUKIN-8; SULFONAMIDES;

EID: 84961878456     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-208094corr1     Document Type: Erratum

References (36)

1. Heiberg T, Kvien TK. Preferences for improved health examined in 1, 024 patients with rheumatoid arthritis: pain has highest priority. Arthritis Rheum 2002;47:391-7.
2. Rantapää-Dahlqvist S, de Jong BAW, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.
3. Bos WH, Wolbink GJ, Boers M, et al. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis 2010;69:490-4.
4. van Steenbergen HW, van Nies JAB, Huizinga TWJ, et al. Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI. Ann Rheum Dis 2015;74:1225-32.
5. McWilliams DF, Zhang W, Mansell JS, et al. Predictors of change in bodily pain in early rheumatoid arthritis: an inception cohort study. Arthritis Care Res (Hoboken) 2012;64:1505-13.
6. American College of Rheumatology Pain Management Task Force. Report of the American College of Rheumatology Pain Management Task Force. Arthritis Care Res (Hoboken) 2010;62:590-9.
7. Kojima M, Kojima T, Suzuki S, et al. Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Rheum 2009;61:1018-24.
8. Lee YC, Cui J, Lu B, et al. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study. Arthritis Res Ther 2011;13:R83.
9. Schellekens GA, de Jong BA, van den Hoogen FH, et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81.
10. Klareskog L, Lundberg K, Malmström V. Autoimmunity in rheumatoid arthritis: citrulline immunity and beyond. Adv Immunol 2013;118:129-58.
11. van de Sande MGH, de Hair MJH, van der Leij C, et al. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann Rheum Dis 2011;70:772-7.
12. Kuhn KA, Kulik L, Tomooka B, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006;116:961-73.
13. Uysal H, Bockermann R, Nandakumar KS, et al. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med 2009;206:449-62.
14. Harre U, Georgess D, Bang H, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 2012;122:1791-802.
15. Klein CJ, Lennon VA, Aston PA, et al. Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology 2012;79:1136-44.
16. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
17. Ossipova E, Cerqueira CF, Reed E, et al. Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint. Arthritis Res Ther 2014;16:R167.
18. Amara K, Steen J, Murray F, et al. Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med 2013;210:445-55.
19. Bas DB, Su J, Sandor K, et al. Collagen antibody-induced arthritis evokes persistent pain with spinal glial involvement and transient prostaglandin dependency. Arthritis Rheum 2012;64:3886-96.
20. Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53:55-63.
21. Dirig DM, Salami A, Rathbun ML, et al. Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J Neurosci Methods 1997;76:183-91.
22. Cobos EJ, Ghasemlou N, Araldi D, et al. Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia. Pain 2012;153:876-84.
23. Athanasou NA, Puddle B, Quinn J, et al. Use of monoclonal antibodies to recognise osteoclasts in routinely processed bone biopsy specimens. J Clin Pathol 1991;44:664-6.
24. Wu J, Glimcher LH, Aliprantis AO. HCO3-/Cl-anion exchanger SLC4A2 is required for proper osteoclast differentiation and function. Proc Natl Acad Sci USA 2008;105:16934-9.
25. Krishnamurthy A, Vijay J, Hensvold H, et al. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone destruction. Ann Rheum Dis 2016;75:721-9.
26. Cunha TM, Verri WA, Silva JS, et al. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA 2005;102:1755-60.
27. Guerrero ATG, Cunha TM, Verri WA, et al. Toll-like receptor 2/MyD88 signaling mediates zymosan-induced joint hypernociception in mice: participation of TNF-a, IL-1p and CXCL1/KC. Eur J Pharmacol 2012;674:51-7.
28. Zhang Z-J, Cao D-L, Zhang X, et al. Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons. Pain 2013;154:2185-97.
29. Qin X, Wan Y, Wang X. CCL2 and CXCL1 trigger calcitonin gene-related peptide release by exciting primary nociceptive neurons. J Neurosci Res 2005;82:51-62.
30. Wang J-G, Strong JA, Xie W, et al. The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons. Mol Pain 2008;4:38.
31. Yang R-H, Strong JA, Zhang J-M. NF-kappa B mediated enhancement of potassium currents by the chemokine CXCL1/growth related oncogene in small diameter rat sensory neurons. Mol Pain 2009;5:26.
32. Dong F, Du Y-R, Xie W, et al. Increased function of the TRPV1 channel in small sensory neurons after local inflammation or in vitro exposure to the pro-inflammatory cytokine GRO/KC. Neurosci Bull 2012;28:155-64.
33. Harre U, Lang SC, Pfeifle R, et al. Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat Commun 2015;6:6651.
34. Negishi-Koga T, Gober H-J, Sumiya E, et al. Immune complexes regulate bone metabolism through FcRy signalling. Nat Commun 2015;6:6637.
35. Rönnelid J, Wick MC, Lampa J, et al. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 2005;64:1744-9.
36. Bos WH, Bartelds GM, Wolbink GJ, et al. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis. J Rheumatol 2008;35:1972-7.